LaFleur & Godfrey’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.4M | Buy |
73,119
+1,944
| +3% | +$418K | 2.18% | 12 |
|
|
2026
Q1 | $15.5M | Sell |
71,175
-514
| -0.7% | -$114K | 1.93% | 15 |
|
|
2025
Q4 | $16.4M | Sell |
71,689
-3,873
| -5% | -$882K | 1.98% | 15 |
|
|
2025
Q3 | $17.5M | Sell |
75,562
-2,975
| -4% | -$606K | 2.12% | 14 |
|
|
2025
Q2 | $14.6M | Sell |
78,537
-804
| -1% | -$149K | 1.82% | 19 |
|
|
2025
Q1 | $16.6M | Sell |
79,341
-55
| -0.1% | -$10.7K | 2.26% | 13 |
|
|
2024
Q4 | $14.1M | Buy |
79,396
+3,108
| +4% | +$571K | 1.93% | 16 |
|
|
2024
Q3 | $15.1M | Sell |
76,288
-1,805
| -2% | -$337K | 2.08% | 14 |
|
|
2024
Q2 | $13.4M | Sell |
78,093
-1,259
| -2% | -$209K | 1.97% | 15 |
|
|
2024
Q1 | $14.5M | Sell |
79,352
-9,731
| -11% | -$1.68M | 2.14% | 13 |
|
|
2023
Q4 | $13.8M | Buy |
89,083
+1,133
| +1% | +$165K | 2.06% | 15 |
|
|
2023
Q3 | $13.1M | Buy |
87,950
+121
| +0.1% | +$17.8K | 2.1% | 15 |
|
|
2023
Q2 | $11.8M | Buy |
87,829
+811
| +0.9% | +$119K | 1.77% | 18 |
|
|
2023
Q1 | $13.9M | Sell |
87,018
-1,879
| -2% | -$287K | 2.27% | 13 |
|
|
2022
Q4 | $14.4M | Sell |
88,897
-2,614
| -3% | -$401K | 2.4% | 12 |
|
|
2022
Q3 | $12.3M | Sell |
91,511
-7,513
| -8% | -$1.08M | 2.19% | 12 |
|
|
2022
Q2 | $15.2M | Sell |
99,024
-22,693
| -19% | -$3.47M | 2.4% | 10 |
|
|
2022
Q1 | $19.7M | Sell |
121,717
-6,017
| -5% | -$874K | 2.65% | 8 |
|
|
2021
Q4 | $17.3M | Sell |
127,734
-2,324
| -2% | -$275K | 2.22% | 12 |
|
|
2021
Q3 | $14M | Buy |
130,058
+12,836
| +11% | +$1.47M | 1.94% | 11 |
|
|
2021
Q2 | $13.2M | Buy |
117,222
+3,348
| +3% | +$377K | 1.89% | 12 |
|
|
2021
Q1 | $12.3M | Buy |
113,874
+5,148
| +5% | +$551K | 2.4% | 12 |
|
|
2020
Q4 | $11.7M | Buy |
108,726
+6,307
| +6% | +$606K | 2.39% | 14 |
|
|
2020
Q3 | $8.97M | Sell |
102,419
-1,180
| -1% | -$111K | 2.02% | 20 |
|
|
2020
Q2 | $10.2M | Sell |
103,599
-3,049
| -3% | -$268K | 2.6% | 15 |
|
|
2020
Q1 | $8.13M | Sell |
106,648
-745
| -0.7% | -$63.5K | 2.42% | 16 |
|
|
2019
Q4 | $9.51M | Sell |
107,393
-1,215
| -1% | -$101K | 2.15% | 17 |
|
|
2019
Q3 | $8.22M | Buy |
108,608
+740
| +0.7% | +$50.7K | 2.02% | 18 |
|
|
2019
Q2 | $7.84M | Sell |
107,868
-1,695
| -2% | -$133K | 1.96% | 20 |
|
|
2019
Q1 | $8.83M | Sell |
109,563
-2,380
| -2% | -$195K | 2.28% | 16 |
|
|
2018
Q4 | $10.3M | Buy |
111,943
+1,050
| +0.9% | +$92.3K | 2.91% | 13 |
|
|
2018
Q3 | $10.5M | Buy |
110,893
+5,220
| +5% | +$495K | 2.53% | 15 |
|
|
2018
Q2 | $9.79M | Sell |
105,673
-2,438
| -2% | -$238K | 2.45% | 17 |
|
|
2018
Q1 | $10.2M | Buy |
108,111
+702
| +0.7% | +$77.1K | 2.57% | 13 |
|
|
2017
Q4 | $10.4M | Sell |
107,409
-2,610
| -2% | -$246K | 2.55% | 16 |
|
|
2017
Q3 | $9.78M | Sell |
110,019
-2,025
| -2% | -$154K | 2.56% | 13 |
|
|
2017
Q2 | $8.12M | Sell |
112,044
-1,985
| -2% | -$133K | 2.14% | 16 |
|
|
2017
Q1 | $7.43M | Sell |
114,029
-86,545
| -43% | -$5.44M | 2.01% | 18 |
|
|
2016
Q4 | $12.6M | Sell |
200,574
-30,235
| -13% | -$1.85M | 3.52% | 7 |
|
|
2016
Q3 | $14.6M | Sell |
230,809
-9,145
| -4% | -$592K | 4.2% | 5 |
|
|
2016
Q2 | $14.9M | Buy |
239,954
+8,585
| +4% | +$523K | 4.4% | 4 |
|
|
2016
Q1 | $13.2M | Buy |
231,369
+3,130
| +1% | +$174K | 4.02% | 5 |
|
|
2015
Q4 | $13.5M | Buy |
228,239
+10,320
| +5% | +$594K | 4.01% | 7 |
|
|
2015
Q3 | $11.9M | Buy |
217,919
+21,390
| +11% | +$1.39M | 3.54% | 9 |
|
|
2015
Q2 | $13.2M | Buy |
196,529
+19,355
| +11% | +$1.26M | 3.65% | 8 |
|
|
2015
Q1 | $10.4M | Buy |
177,174
+65,940
| +59% | +$3.98M | 2.78% | 11 |
|
|
2014
Q4 | $7.28M | Buy |
111,234
+9,270
| +9% | +$584K | 1.95% | 14 |
|
|
2014
Q3 | $5.89M | Buy |
101,964
+10,590
| +12% | +$588K | 1.61% | 17 |
|
|
2014
Q2 | $5.16M | Buy |
91,374
+10,575
| +13% | +$555K | 1.37% | 28 |
|
|
2014
Q1 | $4.15M | Buy |
80,799
+4,160
| +5% | +$210K | 1.15% | 30 |
|
|
2013
Q4 | $4.05M | Buy |
76,639
+11,560
| +18% | +$568K | 1.12% | 31 |
|
|
2013
Q3 | $2.91M | Sell |
65,079
-2,782
| -4% | -$123K | 0.84% | 37 |
|
|
2013
Q2 | $2.81M | Buy |
+67,861
| New | +$2.97M | 0.84% | 39 |
|
Other funds holding ABBV
ECSS
ATO
LaFleur & Godfrey's ABBV Position: Q2 2026 in Review
LaFleur & Godfrey increased its AbbVie (ABBV) stake by 2.7% in Q2 2026, buying an estimated $418K and bringing the position to 73,119 shares worth $18.4M. The position accounts for 2.18% of the portfolio, ranked #12.
LaFleur & Godfrey first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.7M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- LaFleur & Godfrey held 73,119 shares of AbbVie worth $18.4M as of Q2 2026.
- LaFleur & Godfrey bought 1,944 AbbVie shares in Q2 2026, an estimated $418K.
- AbbVie made up 2.18% of LaFleur & Godfrey's portfolio in Q2 2026, its #12 holding.
- LaFleur & Godfrey first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- LaFleur & Godfrey's AbbVie position peaked at $19.7M in Q1 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.